Impressive

Zacks Small Cap Research – CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Update on the DrugSorb-ATR Regulatory Process Management reiterated that their De Novo DrugSorb-ATR submission continued to be in interactive review with FDA, that their Medical Device License application to Health Canada was in advanced review, and that they continue to expect regulatory decisions in … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more

Andrew Radding was named to the 2025 Finest Legal professionals in America Information for his spectacular Legal Protection apply, in each the Normal Observe and White-Collar classes. – Go Well being Professional

by
Andrew Radding was named to the 2025 Finest Legal professionals in America Information for his spectacular Legal Protection apply, in each the Normal Observe and White-Collar classes. – Go Well being Professional

Andrew Radding, of counsel at Brown, Goldstein & Levy, was acknowledged by the 2025 Finest Legal professionals in America Information for his exemplary Legal Protection apply, in each the Normal Observe and White-Collar classes. That is his sixth consecutive yr Andrew has obtained this distinction. All through the span of his 50-year profession, Andrew has … Read more